Death | Disease progression | |||||
Crude hazard ratio (95% CI) | Adjusted hazard ratio (95% CI)* | p Value | Crude hazard ratio (95% CI) | Adjusted hazard ratio (95% CI)* | p Value | |
Centre | ||||||
1 | 1 | 1 | 0.07 | 1 | 1 | 0.03 |
2 | 1.03 (0.55–1.92) | 1.10 (0.44–2.77) | 1.03 (0.72–1.47) | 0.94 (0.60–1.48) | ||
3 | 1.99 (1.15–3.45) | 2.70 (1.19–6.11) | 1.76 (1.27–2.44) | 1.56 (1.03–2.35) | ||
4 | 1.09 (0.49–2.43) | 0.79 (0.21–2.99) | 1.13 (0.72–1.79) | 0.98 (0.54–1.79) | ||
5 | 1.09 (0.60–1.97) | 1.39 (0.60–3.20) | 1.50 (1.10–2.06) | 1.32 (0.89–1.95) | ||
6 | 1.24 (0.74–2.09) | 0.90 (0.32–2.50) | 1.04 (0.76–1.41) | 0.75 (0.46–1.24) | ||
Period of HIV diagnosis | ||||||
⩽2000 | 1 | 1 | 0.32 | 1 | 1 | 0.50 |
>2000 | 0.99 (0.66–1.49) | 1.39 (0.73–2.67) | 1.04 (0.95–1.13) | 1.11 (0.82–1.52) | ||
Age at HIV diagnosis (years) | ||||||
<30 | 1 | 1 | 0.11 | 1 | 1 | 0.80 |
30–39 | 1.47 (0.84–2.59) | 1.80 (0.74–4.38) | 1.20 (0.91–1.57) | 0.96 (0.68–1.37) | ||
40–49 | 3.32 (1.92–5.74) | 2.07 (0.81–5.29) | 1.71 (1.29–2.27) | 0.99 (0.67–1.46) | ||
50–59 | 3.43 (1.80–6.54) | 3.18 (1.17–8.68) | 1.78 (1.25–2.54) | 1.27 (0.79–2.05) | ||
⩾60 | 8.12 (4.14–15.9) | 5.20 (1.34–20.13) | 2.48 (1.57–3.94) | 1.21 (0.53–2.78) | ||
Route of HIV infection | ||||||
Homosexual/bisexual | 1 | 1 | 0.19 | 1 | 1 | 0.18 |
Heterosexual men | 2.08 (1.34–3.21) | 1.70 (0.84–3.42) | 1.61 (1.25–2.08) | 1.35 (0.96–1.91) | ||
Heterosexual women | 0.50 (0.26–0.95) | 0.76 (0.31–1.86) | 0.87 (0.66–1.17) | 0.99 (0.67–1.45) | ||
Injecting drug use | 2.86 (1.46–5.60) | 1.66 (0.52–5.31) | 2.20 (1.46–3.31) | 1.83 (1.01–3.31) | ||
Unknown | 2.74 (1.62–4.61) | 2.00 (0.85–4.67) | 1.58 (1.12–2.22) | 1.41 (0.87–2.28) | ||
Others | 1.77 (0.75–4.19) | 2.53 (0.80–8.02) | 1.06 (0.59–1.92) | 1.08 (0.49–2.36) | ||
Late diagnosis | ||||||
No | 1 | 1 | <0.0001 | |||
Yes | 7.79 (4.93–12.30) | 9.18 (4.32–19.48) | ||||
Employment status† | ||||||
Working | 1 | 1 | <0.0001 | 1 | 1 | 0.006 |
Non-working | 3.59 (2.08–6.20) | 3.75 (2.11–6.66) | 1.64 (1.23–2.19) | 1.59 (1.17–2.15) | ||
Others | 1.90 (0.82–4.40) | 1.10 (0.38–3.14) | 0.98 (0.61–1.57) | 0.85 (0.50–1.46) | ||
Antiretroviral therapy | ||||||
No | 1 | 1 | <0.0001 | 1 | 1 | <0.0001 |
Yes | 0.49 (0.33–0.74) | 0.18 (0.08–0.41) | 0.51 (0.40–0.64) | 0.29 (0.20–0.42) |
*Results from Cox regression analyses. Association between death or disease progression and chronic infection, stable partnership, having children and tobacco consumption were above the threshold of 0.10 in bivariate analysis and were not entered in the model. †Totals vary due to missing data.